TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2019

Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.

Sebastian Mondaca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.